Convalescent plasma therapy in an immunocompromised patient with multiple COVID‐19 flares: a case report
Abstract Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID‐19 pneumonia. We describe the case of a 45‐year‐old immunocompromised patient, who received CP, in order to control multiple COVID‐19 flares and prolonged SARS‐CoV‐2 v...
Main Authors: | Frini Karaolidou, Natasa‐Eleni Loutsidi, Zois Mellios, Edison Jahaj, Konstantinos Eleftheriou, Maria Pagoni, Ioannis Mpaltadakis, Athanasios‐Meletios Dimopoulos, Ioannis Kalomenidis, Apostolos G. Pappas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-12-01
|
Series: | Respirology Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/rcr2.858 |
Similar Items
-
Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection
by: Nikolaos Orologas-Stavrou, et al.
Published: (2020-12-01) -
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis
by: Vasiliki Pappa, et al.
Published: (2021-04-01) -
Efficacy of convalescent plasma therapy in immunocompromised patients with COVID-19: A case report
by: Genni Casarola, et al.
Published: (2021-11-01) -
Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
by: Thomas P. Thomopoulos, et al.
Published: (2021-09-01) -
Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
by: Latha Dulipsingh, et al.
Published: (2023-06-01)